Biotech · Private company
Incuron
Track this companyFree. Adds Incuron to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- CBL0137Phase 1 · Hematological MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- CBL0137Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in MelanomaEARLY_PHASE1 · RECRUITING · started Nov 30, 2022ClinicalTrials.gov NCT05498792 · fetched Nov 12, 2026
- CBL0137 in Treating Patients With Advanced Extremity Melanoma or SarcomaPHASE1 · TERMINATED · started Jul 1, 2019ClinicalTrials.gov NCT03727789 · fetched Nov 12, 2026
- Study of IV CBL0137 in Previously Treated Hematological SubjectsPHASE1 · TERMINATED · started Jan 1, 2017ClinicalTrials.gov NCT02931110 · fetched Nov 12, 2026
- A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid NeoplasmPHASE1 · COMPLETED · started Jul 1, 2013ClinicalTrials.gov NCT01905228 · fetched Nov 12, 2026